The global market for Over-The-Counter (OTC) Drugs was estimated to be worth US$ 1690.1 million in 2023 and is forecast to a readjusted size of US$ 2642.7 million by 2030 with a CAGR of 6.6% during the forecast period 2024-2030

Over-The-Counter (OTC) Drugs - Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Over-The-Counter (OTC) Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Over-The-Counter (OTC) Drugs by region & country, by Type, and by Sale Channel.

The Over-The-Counter (OTC) Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Over-The-Counter (OTC) Drugs.

Market Segmentation

Scope of Over-The-Counter (OTC) Drugs - Market Report

Report Metric	Details
Report Name	Over-The-Counter (OTC) Drugs - Market
Forecasted market size in 2030	US$ 2642.7 million
CAGR	6.6%
Forecasted years	2024 - 2030
Segment by Type:	Cold and Flu Products Analgesics Dermatological Products Gastrointestinal Products Vitamin Other
Segment by Sale Channel	Hospital Pharmacy Retail Pharmacy Online Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer, Boehringer Ingelheim, GSK, Novartis, Pfizer, PGT healthcare, Sanofi, Teva Pharmaceuticals, Takeda, Cipla, Sun Pharmaceutical Industries, Glenmark, Innovus Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Over-The-Counter (OTC) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Sale Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Over-The-Counter (OTC) Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Over-The-Counter (OTC) Drugs in country level. It provides sigmate data by Type, and by Sale Channel for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Over-The-Counter (OTC) Drugs - Market size in 2030?

Ans: The Over-The-Counter (OTC) Drugs - Market size in 2030 will be US$ 2642.7 million.

Who are the main players in the Over-The-Counter (OTC) Drugs - Market report?

Ans: The main players in the Over-The-Counter (OTC) Drugs - Market are Bayer, Boehringer Ingelheim, GSK, Novartis, Pfizer, PGT healthcare, Sanofi, Teva Pharmaceuticals, Takeda, Cipla, Sun Pharmaceutical Industries, Glenmark, Innovus Pharmaceuticals

What are the Type segmentation covered in the Over-The-Counter (OTC) Drugs - Market report?

Ans: The Types covered in the Over-The-Counter (OTC) Drugs - Market report are Cold and Flu Products, Analgesics, Dermatological Products, Gastrointestinal Products, Vitamin, Other

1 Market Overview

1.1 Over-The-Counter (OTC) Drugs Product Introduction

1.2 Global Over-The-Counter (OTC) Drugs Market Size Forecast

1.2.1 Global Over-The-Counter (OTC) Drugs Sales Value (2019-2030)

1.2.2 Global Over-The-Counter (OTC) Drugs Sales Volume (2019-2030)

1.2.3 Global Over-The-Counter (OTC) Drugs Sales Price (2019-2030)

1.3 Over-The-Counter (OTC) Drugs Market Trends & Drivers

1.3.1 Over-The-Counter (OTC) Drugs Industry Trends

1.3.2 Over-The-Counter (OTC) Drugs Market Drivers & Opportunity

1.3.3 Over-The-Counter (OTC) Drugs Market Challenges

1.3.4 Over-The-Counter (OTC) Drugs Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Over-The-Counter (OTC) Drugs Players Revenue Ranking (2023)

2.2 Global Over-The-Counter (OTC) Drugs Revenue by Company (2019-2024)

2.3 Global Over-The-Counter (OTC) Drugs Players Sales Volume Ranking (2023)

2.4 Global Over-The-Counter (OTC) Drugs Sales Volume by Company Players (2019-2024)

2.5 Global Over-The-Counter (OTC) Drugs Average Price by Company (2019-2024)

2.6 Key Manufacturers Over-The-Counter (OTC) Drugs Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Over-The-Counter (OTC) Drugs Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Over-The-Counter (OTC) Drugs

2.9 Over-The-Counter (OTC) Drugs Market Competitive Analysis

2.9.1 Over-The-Counter (OTC) Drugs Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Over-The-Counter (OTC) Drugs Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over-The-Counter (OTC) Drugs as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Cold and Flu Products

3.1.2 Analgesics

3.1.3 Dermatological Products

3.1.4 Gastrointestinal Products

3.1.5 Vitamin

3.1.6 Other

3.2 Global Over-The-Counter (OTC) Drugs Sales Value by Type

3.2.1 Global Over-The-Counter (OTC) Drugs Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Over-The-Counter (OTC) Drugs Sales Value, by Type (2019-2030)

3.2.3 Global Over-The-Counter (OTC) Drugs Sales Value, by Type (%) (2019-2030)

3.3 Global Over-The-Counter (OTC) Drugs Sales Volume by Type

3.3.1 Global Over-The-Counter (OTC) Drugs Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Over-The-Counter (OTC) Drugs Sales Volume, by Type (2019-2030)

3.3.3 Global Over-The-Counter (OTC) Drugs Sales Volume, by Type (%) (2019-2030)

3.4 Global Over-The-Counter (OTC) Drugs Average Price by Type (2019-2030)

4 Segmentation by Sale Channel

4.1 Introduction by Sale Channel

4.1.1 Hospital Pharmacy

4.1.2 Retail Pharmacy

4.1.3 Online Pharmacy

4.2 Global Over-The-Counter (OTC) Drugs Sales Value by Sale Channel

4.2.1 Global Over-The-Counter (OTC) Drugs Sales Value by Sale Channel (2019 VS 2023 VS 2030)

4.2.2 Global Over-The-Counter (OTC) Drugs Sales Value, by Sale Channel (2019-2030)

4.2.3 Global Over-The-Counter (OTC) Drugs Sales Value, by Sale Channel (%) (2019-2030)

4.3 Global Over-The-Counter (OTC) Drugs Sales Volume by Sale Channel

4.3.1 Global Over-The-Counter (OTC) Drugs Sales Volume by Sale Channel (2019 VS 2023 VS 2030)

4.3.2 Global Over-The-Counter (OTC) Drugs Sales Volume, by Sale Channel (2019-2030)

4.3.3 Global Over-The-Counter (OTC) Drugs Sales Volume, by Sale Channel (%) (2019-2030)

4.4 Global Over-The-Counter (OTC) Drugs Average Price by Sale Channel (2019-2030)

5 Segmentation by Region

5.1 Global Over-The-Counter (OTC) Drugs Sales Value by Region

5.1.1 Global Over-The-Counter (OTC) Drugs Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Over-The-Counter (OTC) Drugs Sales Value by Region (2019-2024)

5.1.3 Global Over-The-Counter (OTC) Drugs Sales Value by Region (2025-2030)

5.1.4 Global Over-The-Counter (OTC) Drugs Sales Value by Region (%), (2019-2030)

5.2 Global Over-The-Counter (OTC) Drugs Sales Volume by Region

5.2.1 Global Over-The-Counter (OTC) Drugs Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Over-The-Counter (OTC) Drugs Sales Volume by Region (2019-2024)

5.2.3 Global Over-The-Counter (OTC) Drugs Sales Volume by Region (2025-2030)

5.2.4 Global Over-The-Counter (OTC) Drugs Sales Volume by Region (%), (2019-2030)

5.3 Global Over-The-Counter (OTC) Drugs Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Over-The-Counter (OTC) Drugs Sales Value, 2019-2030

5.4.2 North America Over-The-Counter (OTC) Drugs Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Over-The-Counter (OTC) Drugs Sales Value, 2019-2030

5.5.2 Europe Over-The-Counter (OTC) Drugs Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Over-The-Counter (OTC) Drugs Sales Value, 2019-2030

5.6.2 Asia Pacific Over-The-Counter (OTC) Drugs Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Over-The-Counter (OTC) Drugs Sales Value, 2019-2030

5.7.2 South America Over-The-Counter (OTC) Drugs Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Over-The-Counter (OTC) Drugs Sales Value, 2019-2030

5.8.2 Middle East & Africa Over-The-Counter (OTC) Drugs Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Over-The-Counter (OTC) Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Over-The-Counter (OTC) Drugs Sales Value

6.2.1 Key Countries/Regions Over-The-Counter (OTC) Drugs Sales Value, 2019-2030

6.2.2 Key Countries/Regions Over-The-Counter (OTC) Drugs Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Over-The-Counter (OTC) Drugs Sales Value, 2019-2030

6.3.2 United States Over-The-Counter (OTC) Drugs Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Over-The-Counter (OTC) Drugs Sales Value by Sale Channel, 2023 VS 2030

6.4 Europe

6.4.1 Europe Over-The-Counter (OTC) Drugs Sales Value, 2019-2030

6.4.2 Europe Over-The-Counter (OTC) Drugs Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Over-The-Counter (OTC) Drugs Sales Value by Sale Channel, 2023 VS 2030

6.5 China

6.5.1 China Over-The-Counter (OTC) Drugs Sales Value, 2019-2030

6.5.2 China Over-The-Counter (OTC) Drugs Sales Value by Type (%), 2023 VS 2030

6.5.3 China Over-The-Counter (OTC) Drugs Sales Value by Sale Channel, 2023 VS 2030

6.6 Japan

6.6.1 Japan Over-The-Counter (OTC) Drugs Sales Value, 2019-2030

6.6.2 Japan Over-The-Counter (OTC) Drugs Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Over-The-Counter (OTC) Drugs Sales Value by Sale Channel, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Over-The-Counter (OTC) Drugs Sales Value, 2019-2030

6.7.2 South Korea Over-The-Counter (OTC) Drugs Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Over-The-Counter (OTC) Drugs Sales Value by Sale Channel, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Over-The-Counter (OTC) Drugs Sales Value, 2019-2030

6.8.2 Southeast Asia Over-The-Counter (OTC) Drugs Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Over-The-Counter (OTC) Drugs Sales Value by Sale Channel, 2023 VS 2030

6.9 India

6.9.1 India Over-The-Counter (OTC) Drugs Sales Value, 2019-2030

6.9.2 India Over-The-Counter (OTC) Drugs Sales Value by Type (%), 2023 VS 2030

6.9.3 India Over-The-Counter (OTC) Drugs Sales Value by Sale Channel, 2023 VS 2030

7 Company Profiles

7.1 Bayer

7.1.1 Bayer Company Information

7.1.2 Bayer Introduction and Business Overview

7.1.3 Bayer Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Bayer Over-The-Counter (OTC) Drugs Product Offerings

7.1.5 Bayer Recent Development

7.2 Boehringer Ingelheim

7.2.1 Boehringer Ingelheim Company Information

7.2.2 Boehringer Ingelheim Introduction and Business Overview

7.2.3 Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Boehringer Ingelheim Over-The-Counter (OTC) Drugs Product Offerings

7.2.5 Boehringer Ingelheim Recent Development

7.3 GSK

7.3.1 GSK Company Information

7.3.2 GSK Introduction and Business Overview

7.3.3 GSK Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.3.4 GSK Over-The-Counter (OTC) Drugs Product Offerings

7.3.5 GSK Recent Development

7.4 Novartis

7.4.1 Novartis Company Information

7.4.2 Novartis Introduction and Business Overview

7.4.3 Novartis Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Novartis Over-The-Counter (OTC) Drugs Product Offerings

7.4.5 Novartis Recent Development

7.5 Pfizer

7.5.1 Pfizer Company Information

7.5.2 Pfizer Introduction and Business Overview

7.5.3 Pfizer Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Pfizer Over-The-Counter (OTC) Drugs Product Offerings

7.5.5 Pfizer Recent Development

7.6 PGT healthcare

7.6.1 PGT healthcare Company Information

7.6.2 PGT healthcare Introduction and Business Overview

7.6.3 PGT healthcare Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.6.4 PGT healthcare Over-The-Counter (OTC) Drugs Product Offerings

7.6.5 PGT healthcare Recent Development

7.7 Sanofi

7.7.1 Sanofi Company Information

7.7.2 Sanofi Introduction and Business Overview

7.7.3 Sanofi Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Sanofi Over-The-Counter (OTC) Drugs Product Offerings

7.7.5 Sanofi Recent Development

7.8 Teva Pharmaceuticals

7.8.1 Teva Pharmaceuticals Company Information

7.8.2 Teva Pharmaceuticals Introduction and Business Overview

7.8.3 Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Product Offerings

7.8.5 Teva Pharmaceuticals Recent Development

7.9 Takeda

7.9.1 Takeda Company Information

7.9.2 Takeda Introduction and Business Overview

7.9.3 Takeda Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Takeda Over-The-Counter (OTC) Drugs Product Offerings

7.9.5 Takeda Recent Development

7.10 Cipla

7.10.1 Cipla Company Information

7.10.2 Cipla Introduction and Business Overview

7.10.3 Cipla Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Cipla Over-The-Counter (OTC) Drugs Product Offerings

7.10.5 Cipla Recent Development

7.11 Sun Pharmaceutical Industries

7.11.1 Sun Pharmaceutical Industries Company Information

7.11.2 Sun Pharmaceutical Industries Introduction and Business Overview

7.11.3 Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Product Offerings

7.11.5 Sun Pharmaceutical Industries Recent Development

7.12 Glenmark

7.12.1 Glenmark Company Information

7.12.2 Glenmark Introduction and Business Overview

7.12.3 Glenmark Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Glenmark Over-The-Counter (OTC) Drugs Product Offerings

7.12.5 Glenmark Recent Development

7.13 Innovus Pharmaceuticals

7.13.1 Innovus Pharmaceuticals Company Information

7.13.2 Innovus Pharmaceuticals Introduction and Business Overview

7.13.3 Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Product Offerings

7.13.5 Innovus Pharmaceuticals Recent Development

8 Industry Chain Analysis

8.1 Over-The-Counter (OTC) Drugs Industrial Chain

8.2 Over-The-Counter (OTC) Drugs Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Over-The-Counter (OTC) Drugs Sales Model

8.5.2 Sales Channel

8.5.3 Over-The-Counter (OTC) Drugs Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Sun Pharmaceutical Industries

Glenmark

Innovus Pharmaceuticals

List of Tables

Table 1. Over-The-Counter (OTC) Drugs Market Trends

Table 2. Over-The-Counter (OTC) Drugs Market Drivers & Opportunity

Table 3. Over-The-Counter (OTC) Drugs Market Challenges

Table 4. Over-The-Counter (OTC) Drugs Market Restraints

Table 5. Global Over-The-Counter (OTC) Drugs Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Company (2019-2024)

Table 7. Global Over-The-Counter (OTC) Drugs Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Over-The-Counter (OTC) Drugs Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Over-The-Counter (OTC) Drugs Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Over-The-Counter (OTC) Drugs Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Over-The-Counter (OTC) Drugs Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Over-The-Counter (OTC) Drugs

Table 13. Global Over-The-Counter (OTC) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over-The-Counter (OTC) Drugs as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Over-The-Counter (OTC) Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Over-The-Counter (OTC) Drugs Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Over-The-Counter (OTC) Drugs Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Over-The-Counter (OTC) Drugs Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Over-The-Counter (OTC) Drugs Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Over-The-Counter (OTC) Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Over-The-Counter (OTC) Drugs Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Over-The-Counter (OTC) Drugs Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Over-The-Counter (OTC) Drugs Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Over-The-Counter (OTC) Drugs Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Over-The-Counter (OTC) Drugs Sales Value by Sale Channel: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Over-The-Counter (OTC) Drugs Sales Value by Sale Channel (2019-2024) & (US$ Million)

Table 30. Global Over-The-Counter (OTC) Drugs Sales Value by Sale Channel (2025-2030) & (US$ Million)

Table 31. Global Over-The-Counter (OTC) Drugs Sales Market Share in Value by Sale Channel (2019-2024) & (%)

Table 32. Global Over-The-Counter (OTC) Drugs Sales Market Share in Value by Sale Channel (2025-2030) & (%)

Table 33. Global Over-The-Counter (OTC) Drugs Sales Volume by Sale Channel: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Over-The-Counter (OTC) Drugs Sales Volume by Sale Channel (2019-2024) & (K Units)

Table 35. Global Over-The-Counter (OTC) Drugs Sales Volume by Sale Channel (2025-2030) & (K Units)

Table 36. Global Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Sale Channel (2019-2024) & (%)

Table 37. Global Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Sale Channel (2025-2030) & (%)

Table 38. Global Over-The-Counter (OTC) Drugs Price by Sale Channel (2019-2024) & (USD/Unit)

Table 39. Global Over-The-Counter (OTC) Drugs Price by Sale Channel (2025-2030) & (USD/Unit)

Table 40. Global Over-The-Counter (OTC) Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Over-The-Counter (OTC) Drugs Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Over-The-Counter (OTC) Drugs Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Over-The-Counter (OTC) Drugs Sales Value by Region (2019-2024) & (%)

Table 44. Global Over-The-Counter (OTC) Drugs Sales Value by Region (2025-2030) & (%)

Table 45. Global Over-The-Counter (OTC) Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Over-The-Counter (OTC) Drugs Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Over-The-Counter (OTC) Drugs Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Over-The-Counter (OTC) Drugs Sales Volume by Region (2019-2024) & (%)

Table 49. Global Over-The-Counter (OTC) Drugs Sales Volume by Region (2025-2030) & (%)

Table 50. Global Over-The-Counter (OTC) Drugs Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Over-The-Counter (OTC) Drugs Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Over-The-Counter (OTC) Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Over-The-Counter (OTC) Drugs Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Over-The-Counter (OTC) Drugs Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Over-The-Counter (OTC) Drugs Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Over-The-Counter (OTC) Drugs Sales Volume, (2025-2030) & (K Units)

Table 57. Bayer Company Information

Table 58. Bayer Introduction and Business Overview

Table 59. Bayer Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Bayer Over-The-Counter (OTC) Drugs Product Offerings

Table 61. Bayer Recent Development

Table 62. Boehringer Ingelheim Company Information

Table 63. Boehringer Ingelheim Introduction and Business Overview

Table 64. Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. Boehringer Ingelheim Over-The-Counter (OTC) Drugs Product Offerings

Table 66. Boehringer Ingelheim Recent Development

Table 67. GSK Company Information

Table 68. GSK Introduction and Business Overview

Table 69. GSK Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. GSK Over-The-Counter (OTC) Drugs Product Offerings

Table 71. GSK Recent Development

Table 72. Novartis Company Information

Table 73. Novartis Introduction and Business Overview

Table 74. Novartis Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Novartis Over-The-Counter (OTC) Drugs Product Offerings

Table 76. Novartis Recent Development

Table 77. Pfizer Company Information

Table 78. Pfizer Introduction and Business Overview

Table 79. Pfizer Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Pfizer Over-The-Counter (OTC) Drugs Product Offerings

Table 81. Pfizer Recent Development

Table 82. PGT healthcare Company Information

Table 83. PGT healthcare Introduction and Business Overview

Table 84. PGT healthcare Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. PGT healthcare Over-The-Counter (OTC) Drugs Product Offerings

Table 86. PGT healthcare Recent Development

Table 87. Sanofi Company Information

Table 88. Sanofi Introduction and Business Overview

Table 89. Sanofi Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. Sanofi Over-The-Counter (OTC) Drugs Product Offerings

Table 91. Sanofi Recent Development

Table 92. Teva Pharmaceuticals Company Information

Table 93. Teva Pharmaceuticals Introduction and Business Overview

Table 94. Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Product Offerings

Table 96. Teva Pharmaceuticals Recent Development

Table 97. Takeda Company Information

Table 98. Takeda Introduction and Business Overview

Table 99. Takeda Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 100. Takeda Over-The-Counter (OTC) Drugs Product Offerings

Table 101. Takeda Recent Development

Table 102. Cipla Company Information

Table 103. Cipla Introduction and Business Overview

Table 104. Cipla Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 105. Cipla Over-The-Counter (OTC) Drugs Product Offerings

Table 106. Cipla Recent Development

Table 107. Sun Pharmaceutical Industries Company Information

Table 108. Sun Pharmaceutical Industries Introduction and Business Overview

Table 109. Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 110. Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Product Offerings

Table 111. Sun Pharmaceutical Industries Recent Development

Table 112. Glenmark Company Information

Table 113. Glenmark Introduction and Business Overview

Table 114. Glenmark Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 115. Glenmark Over-The-Counter (OTC) Drugs Product Offerings

Table 116. Glenmark Recent Development

Table 117. Innovus Pharmaceuticals Company Information

Table 118. Innovus Pharmaceuticals Introduction and Business Overview

Table 119. Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 120. Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Product Offerings

Table 121. Innovus Pharmaceuticals Recent Development

Table 122. Key Raw Materials Lists

Table 123. Raw Materials Key Suppliers Lists

Table 124. Over-The-Counter (OTC) Drugs Downstream Customers

Table 125. Over-The-Counter (OTC) Drugs Distributors List

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. Over-The-Counter (OTC) Drugs Product Picture

Figure 2. Global Over-The-Counter (OTC) Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Over-The-Counter (OTC) Drugs Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Over-The-Counter (OTC) Drugs Sales Volume (2019-2030) & (K Units)

Figure 5. Global Over-The-Counter (OTC) Drugs Sales Price (2019-2030) & (USD/Unit)

Figure 6. Over-The-Counter (OTC) Drugs Report Years Considered

Figure 7. Global Over-The-Counter (OTC) Drugs Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Over-The-Counter (OTC) Drugs Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Over-The-Counter (OTC) Drugs Revenue in 2023

Figure 10. Over-The-Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Cold and Flu Products Picture

Figure 12. Analgesics Picture

Figure 13. Dermatological Products Picture

Figure 14. Gastrointestinal Products Picture

Figure 15. Vitamin Picture

Figure 16. Other Picture

Figure 17. Global Over-The-Counter (OTC) Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 18. Global Over-The-Counter (OTC) Drugs Sales Value Market Share by Type, 2023 & 2030

Figure 19. Global Over-The-Counter (OTC) Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 20. Global Over-The-Counter (OTC) Drugs Sales Volume Market Share by Type, 2023 & 2030

Figure 21. Global Over-The-Counter (OTC) Drugs Price by Type (2019-2030) & (USD/Unit)

Figure 22. Product Picture of Hospital Pharmacy

Figure 23. Product Picture of Retail Pharmacy

Figure 24. Product Picture of Online Pharmacy

Figure 25. Global Over-The-Counter (OTC) Drugs Sales Value by Sale Channel (2019 VS 2023 VS 2030) & (US$ Million)

Figure 26. Global Over-The-Counter (OTC) Drugs Sales Value Market Share by Sale Channel, 2023 & 2030

Figure 27. Global Over-The-Counter (OTC) Drugs Sales Volume by Sale Channel (2019 VS 2023 VS 2030) & (K Units)

Figure 28. Global Over-The-Counter (OTC) Drugs Sales Volume Market Share by Sale Channel, 2023 & 2030

Figure 29. Global Over-The-Counter (OTC) Drugs Price by Sale Channel (2019-2030) & (USD/Unit)

Figure 30. North America Over-The-Counter (OTC) Drugs Sales Value (2019-2030) & (US$ Million)

Figure 31. North America Over-The-Counter (OTC) Drugs Sales Value by Country (%), 2023 VS 2030

Figure 32. Europe Over-The-Counter (OTC) Drugs Sales Value (2019-2030) & (US$ Million)

Figure 33. Europe Over-The-Counter (OTC) Drugs Sales Value by Country (%), 2023 VS 2030

Figure 34. Asia Pacific Over-The-Counter (OTC) Drugs Sales Value (2019-2030) & (US$ Million)

Figure 35. Asia Pacific Over-The-Counter (OTC) Drugs Sales Value by Country (%), 2023 VS 2030

Figure 36. South America Over-The-Counter (OTC) Drugs Sales Value (2019-2030) & (US$ Million)

Figure 37. South America Over-The-Counter (OTC) Drugs Sales Value by Country (%), 2023 VS 2030

Figure 38. Middle East & Africa Over-The-Counter (OTC) Drugs Sales Value (2019-2030) & (US$ Million)

Figure 39. Middle East & Africa Over-The-Counter (OTC) Drugs Sales Value by Country (%), 2023 VS 2030

Figure 40. Key Countries/Regions Over-The-Counter (OTC) Drugs Sales Value (%), (2019-2030)

Figure 41. Key Countries/Regions Over-The-Counter (OTC) Drugs Sales Volume (%), (2019-2030)

Figure 42. United States Over-The-Counter (OTC) Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 43. United States Over-The-Counter (OTC) Drugs Sales Value by Type (%), 2023 VS 2030

Figure 44. United States Over-The-Counter (OTC) Drugs Sales Value by Sale Channel (%), 2023 VS 2030

Figure 45. Europe Over-The-Counter (OTC) Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 46. Europe Over-The-Counter (OTC) Drugs Sales Value by Type (%), 2023 VS 2030

Figure 47. Europe Over-The-Counter (OTC) Drugs Sales Value by Sale Channel (%), 2023 VS 2030

Figure 48. China Over-The-Counter (OTC) Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 49. China Over-The-Counter (OTC) Drugs Sales Value by Type (%), 2023 VS 2030

Figure 50. China Over-The-Counter (OTC) Drugs Sales Value by Sale Channel (%), 2023 VS 2030

Figure 51. Japan Over-The-Counter (OTC) Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 52. Japan Over-The-Counter (OTC) Drugs Sales Value by Type (%), 2023 VS 2030

Figure 53. Japan Over-The-Counter (OTC) Drugs Sales Value by Sale Channel (%), 2023 VS 2030

Figure 54. South Korea Over-The-Counter (OTC) Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 55. South Korea Over-The-Counter (OTC) Drugs Sales Value by Type (%), 2023 VS 2030

Figure 56. South Korea Over-The-Counter (OTC) Drugs Sales Value by Sale Channel (%), 2023 VS 2030

Figure 57. Southeast Asia Over-The-Counter (OTC) Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 58. Southeast Asia Over-The-Counter (OTC) Drugs Sales Value by Type (%), 2023 VS 2030

Figure 59. Southeast Asia Over-The-Counter (OTC) Drugs Sales Value by Sale Channel (%), 2023 VS 2030

Figure 60. India Over-The-Counter (OTC) Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 61. India Over-The-Counter (OTC) Drugs Sales Value by Type (%), 2023 VS 2030

Figure 62. India Over-The-Counter (OTC) Drugs Sales Value by Sale Channel (%), 2023 VS 2030

Figure 63. Over-The-Counter (OTC) Drugs Industrial Chain

Figure 64. Over-The-Counter (OTC) Drugs Manufacturing Cost Structure

Figure 65. Channels of Distribution (Direct Sales, and Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions